whale怎么读
Comparison of clinical outcomes of conbercept versus ranibizumab treatment for retinopathy of prematurity: a multicentral prospective randomid
在职教育硕士分数线controlled trial
青春随想期刊名称： The British journal of ophthalmology
consultancy
dabi作者： Zhenquan Wu,Jinfeng Zhao,Waiching Lam,Mingmin Yang,Guo-Ming Zhang
polt关键词： drugs;retina;treatment other
cik摘要：Purpo To compare the recurrence rate and surgical complications of retinopathy of prematurity (ROP) between patients treated with intravitreal injection of conbercept (IVC) and intravitreal injection of ranibizumab (IVR) within 6 months. Methods A multicentral prospective, randomid controlled trial was applied from May 2017 to February 2019 for the infants diagnod as aggressive posterior-ROP, zone I or posterior zone II treatment-requiring ROP by binocular indirect ophthalmoscope and RetCam3. The infants were assigned to randomly receive either intravitreal inje
el>fash
ction of 0.25 mg conbercept or 0.25 mg ranibizumab. The recurrence rate, fundus fluorescence angiography (FFA) and surgical complications were examined during the follow-up period of 6 months. Recurrent eyes were retreated by lar or another intravitreal
内容由中国教育图书进出口有限公司引进核能英语
